Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • GenoMax
    Senior Member
    • Feb 2008
    • 7142

    #16
    Originally posted by zillur View Post
    Thank you very much for your kind reply. Here is my bash_profile file:# .bash_profile

    # Get the aliases and functions
    if [ -f ~/.bashrc ]; then
    . ~/.bashrc
    fi

    # User specific environment and startup programs

    PATH=$PATH:$HOME/.local/bin:$HOME/bin

    export PATH


    I am not sure which part I need to edit. I have different tools in different directory, like:

    /home/zillur/Desktop/zillur/Tools/bcftools-1.2

    /home/zillur/Desktop/zillur/Tools/samtools-1.2

    /home/zillur/Desktop/zillur/Tools/bowtie2-2.2.5
    If the executables that you want to run are directly under those top level directories then you would need to edit the PATH line like so:
    Code:
    PATH=$PATH:$HOME/.local/bin:$HOME/bin:/home/zillur/Desktop/zillur/Tools/bcftools-1.2:/home/zillur/Desktop/zillur/Tools/samtools-1.2:/home/zillur/Desktop/zillur/Tools/bowtie2-2.2.5
    BTW: what do you see when you do

    Code:
    $ echo $HOME

    Comment

    • zillur
      Senior Member
      • Sep 2014
      • 106

      #17
      Thank you very much for your kind suggestions. After editing the bash_profile my system is working perfectly and I can run all the tools. Now I want to allow other users to use this tools. How can I manage it.

      Best Regards
      Zillur

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
        by SEQadmin2


        Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

        The systematic characterization of the human proteome has
        ...
        Today, 11:48 AM
      • SEQadmin2
        Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
        by SEQadmin2



        Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
        ...
        07-09-2026, 11:10 AM
      • SEQadmin2
        Cancer Drug Resistance: The Lingering Barrier to Rising Survival
        by SEQadmin2



        Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

        There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
        07-08-2026, 05:17 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, Today, 11:10 AM
      0 responses
      7 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-13-2026, 10:26 AM
      0 responses
      29 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-09-2026, 10:04 AM
      0 responses
      38 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-08-2026, 10:08 AM
      0 responses
      25 views
      0 reactions
      Last Post SEQadmin2  
      Working...